DLAT as a Cuproptosis Promoter and a Molecular Target of Elesclomol in Hepatocellular Carcinoma
ConclusionCuproptosis and DLAT as a promising biomarker could help to determine the prognosis of HCC and may offer novel insights for effective treatment.
Source: Journal of Huazhong University of Science and Technology -- Medical Sciences -- - Category: Research Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Copper | Databases & Libraries | Genetics | Hepatocellular Carcinoma | Liver | Liver Cancer | Research | Science | Study | Urology & Nephrology